Your browser doesn't support javascript.
loading
A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome.
Yoshikawa, Tomoki; Taniguchi, Satoshi; Kato, Hirofumi; Iwata-Yoshikawa, Naoko; Tani, Hideki; Kurosu, Takeshi; Fujii, Hikaru; Omura, Natsumi; Shibamura, Miho; Watanabe, Shumpei; Egawa, Kazutaka; Inagaki, Takuya; Sugimoto, Satoko; Phanthanawiboon, Supranee; Harada, Shizuko; Yamada, Souichi; Fukushi, Shuetsu; Morikawa, Shigeru; Nagata, Noriyo; Shimojima, Masayuki; Saijo, Masayuki.
Afiliação
  • Yoshikawa T; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Taniguchi S; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Kato H; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Iwata-Yoshikawa N; Department of Pathology, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Tani H; Department of Virology, Toyama Institute of Health, Imizu-shi, Toyama, Japan.
  • Kurosu T; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Fujii H; Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari-shi, Ehime, Japan.
  • Omura N; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Shibamura M; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Watanabe S; Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari-shi, Ehime, Japan.
  • Egawa K; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Inagaki T; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Sugimoto S; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Phanthanawiboon S; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Harada S; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Yamada S; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Fukushi S; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Morikawa S; Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Imabari-shi, Ehime, Japan.
  • Nagata N; Department of Pathology, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Shimojima M; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
  • Saijo M; Department of Virology 1, National Institute of Infectious Diseases, Musashimurayama-shi, Tokyo, Japan.
PLoS Pathog ; 17(2): e1008859, 2021 02.
Article em En | MEDLINE | ID: mdl-33534867
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Atenuadas / Vacinas Sintéticas / Proteínas do Envelope Viral / Phlebovirus / Febre Grave com Síndrome de Trombocitopenia / Antígenos Virais / Nucleoproteínas Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Atenuadas / Vacinas Sintéticas / Proteínas do Envelope Viral / Phlebovirus / Febre Grave com Síndrome de Trombocitopenia / Antígenos Virais / Nucleoproteínas Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article